Estimating the respiratory syncytial virus-associated hospitalisation burden in older adults in European countries: a systematic analysis

With respiratory syncytial virus vaccines recently approved for use among older adults, country‑level respiratory syncytial virus (RSV) disease burden estimates are needed to inform local RSV immunisation strategy. We aimed to estimate country‑level RSV hospitalisation burden in older adults in Euro...

Descripción completa

Detalles Bibliográficos
Autores: Zhang, Tiantian, Reeves, Rachel M., Ma, Shihao, Miao, Yumeng, Sun, Shiqi, Panning, Marcus, Orrico Sánchez, Alejandro, Urchueguía‑Fornes, Arantxa, Vuichard‑Gysin, Danielle, Nair, Harish, Fonseca, Maria João, Marijam, Alen, Wang, Xin, Li, You
Tipo de recurso: artículo
Fecha de publicación:2025
País:España
Institución:Universidad Católica de Valencia San Vicente Mártir
Repositorio:RIUCV. Repositorio de la Universidad Católica de Valencia San Vicente Mártir
Idioma:inglés
OAI Identifier:oai:riucv.ucv.es:20.500.12466/6753
Acceso en línea:https://hdl.handle.net/20.500.12466/6753
Access Level:acceso abierto
Palabra clave:Respiratory syncytial virus
Hospitalisation
Burden of disease
Older adults
32 Ciencias Médicas
Descripción
Sumario:With respiratory syncytial virus vaccines recently approved for use among older adults, country‑level respiratory syncytial virus (RSV) disease burden estimates are needed to inform local RSV immunisation strategy. We aimed to estimate country‑level RSV hospitalisation burden in older adults in Europe.